S. 1413 — Introduced in Senate

II 113th CONGRESS 1st Session S. 1413 IN THE SENATE OF THE UNITED STATES July 31, 2013 Mr. Pryor (for himself, Mr. Blunt, Mr. Franken, Mr. Moran, and Mr. Coats) introduced the following bill; which was read twice and referred to the Committee on the Budget A BILL To exempt from sequestration certain fees of the Food and Drug Administration. 1. Short title This Act may be cited as the FDA User Fee Protection Act. 2. Exempting from sequestration certain user fees of Food and Drug Administration The Balanced Budget and Emergency Deficit Control Act of 1985 is amended— (1) in section 255(g)(1)(A) (2 U.S.C. 905(g)(1)(A))— (A) by inserting after Financial Agent Services the following new item: Food and Drug Administration, Salaries and Expenses, but only the portion of appropriations under such account corresponding to fees collected under the Federal Food, Drug, and Cosmetic Act and section 354(r)(1) of the Public Health Service Act (75–9911–0–1–554). ; and (B) by inserting after Reimbursement to Federal Reserve Banks the following new item: Revolving Fund for Certification and Other Services (75–4309–0–3–554).; ; and (2) in section 256(h)(4) (2 U.S.C. 906(h)(4)), by adding at the end the following new subparagraph: (G) The portion of administrative expenses incurred by the Food and Drug Administration that are funded through fees collected under the Federal Food, Drug, and Cosmetic Act and section 354(r)(1) of the Public Health Service Act. .